Literature DB >> 7409414

[Does the calcium antagonist verapamil protect from myocardial damage during tocolysis with beta-sympathicomimetics? (author's transl)].

R Strigl, U Pfeiffer, W Erhardt, G Blümel.   

Abstract

Under general anaesthesia nine mongrel dogs were first injected with fenoteral 0.06 mg/kg/per minute and later with fenoteral 0.06 mg/kg/per minute and verapamil 2 mg/kg/per minute. A microtip manometer was placed into the left ventricle and cardiac pressures continously monitored. The resulting pressure curves were used in micro-computer to calculate the cardiac pressure parameters including the inotropic measurements and the myocardical oxygen consumption. The intravenous infusion of the beta-mimetic fenoterol resulted in marked increase of the cardiac rate and contractility as measured in the different measurement of the ionotrophy. A corresponding increase of the myocardical oxygen consumption was found. The addition of the calcium antagonist verapamil did have no influence of the measured parameters. A protective effect of the calcium antagonist on the myocaridium was excluded in the animal experiment. A protective effect during tocolysis with beta-sympathicomimetics cannot be expected because of the expected low serum concentrations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7409414     DOI: 10.1055/s-2008-1037366

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  1 in total

Review 1.  Risk-benefit assessment of tocolytic drugs.

Authors:  A Wischnik
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.